BIOMAT Database Logo BIOMAT Database Logo

Activity of aminosidine (paromomycin) for Mycobacterium tuberculosis and Mycobacterium avium. 1994

T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago 60612.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010303 Paromomycin An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES. Aminosidine,Catenulin,Estomycin,Hydroxymycin,Neomycin E,Gabbromycin,Humatin,Paramomycin,Paromomycin I,Paromomycin Phosphate,Paromomycin Sulfate,Paromomycin Sulfate (1:1),Paromomycin Sulfate (2:5),Paromomycin, beta-D-Glucopyranosyl-Isomer,Paromomycin, beta D Glucopyranosyl Isomer,beta-D-Glucopyranosyl-Isomer Paromomycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015269 Mycobacterium avium Complex A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs. Battey Bacillus,MAIC,Mycobacterium avium-intracellulare,Mycobacterium avium-intracellulare Complex,Mycobacterium intracellulare,Nocardia intracellularis

Related Publications

T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Early bactericidal activity of paromomycin (aminosidine) in patients with smear-positive pulmonary tuberculosis.
December 2000, Antimicrobial agents and chemotherapy,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
In vivo activity of paromomycin against susceptible and multidrug-resistant Mycobacterium tuberculosis and M. avium complex strains.
February 1994, Antimicrobial agents and chemotherapy,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Bacteriostatic and bactericidal activities of paromomycin against Mycobacterium avium complex isolates.
September 1994, The Journal of antimicrobial chemotherapy,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
October 2016, Antimicrobial agents and chemotherapy,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Comparison of three DNA extraction methods for Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium subsp. avium.
July 2008, Letters in applied microbiology,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.
March 1990, The American review of respiratory disease,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis.
August 1997, Veterinary parasitology,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis.
December 1999, Journal of bacteriology,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis.
December 1990, Tubercle,
T P Kayok, and M V Reddy, and J Chinnaswamy, and L H Danziger, and P R Gangadharam
Etest for susceptibility testing of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare.
July 1994, Diagnostic microbiology and infectious disease,
Copied contents to your clipboard!